Authorizes $4 million per year for fiscal years 2024–2026 to the Department of Health and Human Services for a joint U.S.-Israel program awarding grants to develop health technologies, including AI, vaccines, diagnostic tests, and telemedicine tools, with emphasis on infectious disease research. Israel must provide matching funds. Money can support an existing bilateral program or establish a new one under a 2008 U.S.-Israel science cooperation agreement.
Why it matters
This dedicates federal health research funding to a joint venture with Israel, expanding the scope of U.S.-Israel cooperation beyond military and security assistance into civilian technology development. The matching requirement and focus on dual-use technologies (AI, diagnostics) mean U.S. taxpayers are subsidizing Israeli health-tech capacity in areas with potential civilian and security applications.